Myosin Phosphatase + Myosin Phosphatase 2 Antibody

About the Target

MYPT2 is a target of interest in many antibody-based workflows. Myosin Phosphatase (MP) + Myosin Phosphatase 2, also known as myosin light chain phosphatase, is a Ser/Thr-specific enzyme that plays a key role in regulating smooth muscle contraction and other cellular processes by dephosphorylating the 20 kDa myosin light chain (MLC20). MP is a heterotrimeric holoenzyme composed of a catalytic subunit (PP1c, specifically the β/δ isoform), a regulatory/targeting subunit (MYPT1, PPP1R12A), and a smaller subunit (M20/21) of unclear function. Depending on the literature source, MYPT2 may also be discussed as Myosin Phosphatase + Myosin Phosphatase 2 and Protein phosphatase 1 regulatory subunit 12A.

Reported cellular context includes cytoplasm and cytoskeleton, which can matter when signal is compared across treatments or changing cell states. Following MYPT2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state. In practice, this target is often considered at the family or isoform-group level, so experimental interpretation benefits from matched controls and clear comparison logic.

Research Context

MYPT2 is commonly interpreted in the context of cardiovascular and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and cytoskeleton, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm and cytoskeleton across matched conditions
• changes linked to vascular, contractile, or hemodynamic cell-state cues
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
• co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for MYPT2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in MYPT2 reflect biology rather than handling. When interpreting MYPT2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep MYPT2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.